These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9083486

  • 21. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB, De Almeida MV, Fernandes E, França da Costa C, De Carli GA, Tasca T, Zuanazzi JA.
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [Abstract] [Full Text] [Related]

  • 22. Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
    Mahapatra A, Mativandlela SP, Binneman B, Fourie PB, Hamilton CJ, Meyer JJ, van der Kooy F, Houghton P, Lall N.
    Bioorg Med Chem; 2007 Dec 15; 15(24):7638-46. PubMed ID: 17888665
    [Abstract] [Full Text] [Related]

  • 23. [Retrospective microbiologic evaluation of vaginal cultures].
    Açikgöz ZC, Oztürk Turhan N, Gamberzade S, Ark E, Göçer S.
    Mikrobiyol Bul; 2002 Jan 15; 36(1):23-9. PubMed ID: 12476763
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pyridazine N-oxides. II. Synthesis and in vitro antimicrobial evaluation of 3-chloro-4-carbamoyl-5-aryl-6-methyl-pyridazine N-oxides.
    Gavini E, Juliano C, Mulè A, Pirisino G, Pinna GA.
    Farmaco; 1997 Jan 15; 52(1):67-9. PubMed ID: 9181685
    [Abstract] [Full Text] [Related]

  • 26. The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections.
    Warnke PH, Becker ST, Podschun R, Sivananthan S, Springer IN, Russo PA, Wiltfang J, Fickenscher H, Sherry E.
    J Craniomaxillofac Surg; 2009 Oct 15; 37(7):392-7. PubMed ID: 19473851
    [Abstract] [Full Text] [Related]

  • 27. [Frequency of Gardnerella vaginalis vaginosis and its association with other pathogens causing genital infections in the female].
    Mendoza-González A, Sánchez-Vega JT, Sánchez-Peón I, Ruiz-Sánchez D, Tay-Zavala J.
    Ginecol Obstet Mex; 2001 Jul 15; 69():272-6. PubMed ID: 11588810
    [Abstract] [Full Text] [Related]

  • 28. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.
    Simoes JA, Aroutcheva A, Heimler I, Shott S, Faro S.
    Am J Obstet Gynecol; 2001 Nov 15; 185(5):1186-90. PubMed ID: 11717655
    [Abstract] [Full Text] [Related]

  • 29. The bacteriology of Gardnerella vaginalis.
    Taylor-Robinson D.
    Scand J Urol Nephrol Suppl; 1984 Nov 15; 86():41-55. PubMed ID: 6399409
    [Abstract] [Full Text] [Related]

  • 30. The role of Gardnerella vaginalis in nonspecific vaginitis in intra uterine contraceptive device users.
    Gupta BK, Kumar R, Sofat R, Khurana S, Deepinder.
    Indian J Pathol Microbiol; 1998 Jan 15; 41(1):67-70. PubMed ID: 9581079
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and evaluation of antifungal activity of naphthoquinone derivatives.
    Errante G, La Motta G, Lagana C, Wittebolle V, Sarciron ME, Barret R.
    Eur J Med Chem; 2006 Jun 15; 41(6):773-8. PubMed ID: 16563569
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
    Tandon VK, Yadav DB, Chaturvedi AK, Shukla PK.
    Bioorg Med Chem Lett; 2005 Jul 01; 15(13):3288-91. PubMed ID: 15913995
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA, Lo Bue AM, Chisari G, Gismondo MR, Nicoletti G.
    G Batteriol Virol Immunol; 1986 Jul 01; 79(1-6):16-24. PubMed ID: 3500081
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS, Faidallah HM, Rostom SA.
    Arch Pharm (Weinheim); 2008 Jul 01; 341(7):424-34. PubMed ID: 18574850
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and antimicrobial activity evaluation of some new adamantane derivatives.
    Caliş U, Yarim M, Köksal M, Ozalp M.
    Arzneimittelforschung; 2002 Jul 01; 52(10):778-81. PubMed ID: 12442642
    [Abstract] [Full Text] [Related]

  • 38. N-Alkyl/aryl-4-(3-substituted-3-phenylpropyl)piperazine-1-carbothioamide as dual-action vaginal microbicides with reverse transcriptase inhibition.
    Bala V, Mandalapu D, Gupta S, Jangir S, Kushwaha B, Chhonker YS, Chandasana H, Krishna S, Rawat K, Krishna A, Singh M, Sankhwar SN, Shukla PK, Maikhuri JP, Bhatta RS, Siddiqi MI, Tripathi R, Gupta G, Sharma VL.
    Eur J Med Chem; 2015 Aug 28; 101():640-50. PubMed ID: 26209833
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and in vitro microbiological evaluation of imidazo(4,5-b)pyridinylethoxypiperidones.
    Aridoss G, Balasubramanian S, Parthiban P, Kabilan S.
    Eur J Med Chem; 2006 Feb 28; 41(2):268-75. PubMed ID: 16380194
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives.
    Yildiz-Oren I, Yalcin I, Aki-Sener E, Ucarturk N.
    Eur J Med Chem; 2004 Mar 28; 39(3):291-8. PubMed ID: 15051178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.